Pediatric Immunology Breakthroughs: Can Tolerogenic Therapies Cure Autoimmune Disease? Review Key Takeaways Revolutionary tolerogenic therapies are transforming pediatric autoimmune disease treatment from chronic management to potential cures, offering hope for children with severe conditions. CAR T-cell therapy achieves remarkable results: 7 of 8 pediatric
Tag: precision medicine
The Vitamin D Debate: From Universal Supplement to Precision Therapy
The Vitamin D Debate: From Universal Supplement to Precision Therapy Review Abstract Vitamin D supplementation has evolved from a simple solution to rickets into one of medicine’s most debated therapeutic interventions. This paper examines the current evidence surrounding vitamin D’s role in health and disease,
The Great Biomarker Boom: Are We Overdiagnosing Risk or Finally Personalizing Medicine?
The Great Biomarker Boom: Are We Overdiagnosing Risk or Finally Personalizing Medicine? Review Abstract The rapid expansion of biomarker discovery and clinical application has created both unprecedented opportunities and substantial challenges in modern medicine. This analysis examines whether the current biomarker boom represents genuine progress
Why Biomarker-Driven Treatment Fails: The Hidden Role of Histology
Why Biomarker-Driven Treatment Fails The Hidden Role of Histology Introduction Biomarker-driven treatment has fundamentally transformed oncology, ushering in an era of precision medicine in which therapeutic decisions are increasingly guided by the molecular characteristics of tumors rather than their anatomical origin alone. A
Skin Cancer Incidence Highest In Patients Experiencing Adversity
Skin Cancer Incidence Highest In Patients Experiencing Adversity Overview The influence of emotional states on skin conditions is well-recognized, yet the specific impact of stress on the development of skin cancer remains under-explored. This retrospective study aimed to broaden the understanding of skin cancer risk factors by examining the intricate relationship between
Precision Medication Therapy Strategy In Crohn’s Disease: Financial Advantages
Precision Medication Therapy Strategy In Crohn's Disease: Financial Advantages Overview In this study, the cost-effectiveness of precision-guided dosing (PGD) of infliximab (IFX) for patients with Crohn's disease (CD) who lose response to biologics was evaluated in comparison to two other dose intensification strategies (DIS). A hybrid model combining Markov and decision tree elements
